In prostate cancer, PIM-1 activation is particularly significant, contributing to tumor progression and aggressiveness, especially in castration-resistant prostate cancer (CRPC) (Heyder et al., 2023). The gene discussed is PIM1; the disease is Familial prostate cancer.